Zacks Research Estimates CME Group FY2024 Earnings

CME Group Inc. (NASDAQ:CMEFree Report) – Investment analysts at Zacks Research issued their FY2024 earnings per share estimates for shares of CME Group in a report issued on Wednesday, November 13th. Zacks Research analyst T. De forecasts that the financial services provider will post earnings of $10.21 per share for the year. The consensus estimate for CME Group’s current full-year earnings is $10.22 per share. Zacks Research also issued estimates for CME Group’s Q4 2025 earnings at $2.56 EPS.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the firm earned $2.25 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year.

A number of other equities analysts also recently issued reports on the stock. JPMorgan Chase & Co. increased their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Oppenheimer upped their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average target price of $224.47.

Read Our Latest Research Report on CME Group

CME Group Price Performance

CME Group stock opened at $227.56 on Monday. The company has a market cap of $82.00 billion, a P/E ratio of 23.93, a price-to-earnings-growth ratio of 5.20 and a beta of 0.55. CME Group has a one year low of $190.70 and a one year high of $230.36. The business has a fifty day moving average of $222.80 and a two-hundred day moving average of $210.53. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

Institutional Investors Weigh In On CME Group

Several large investors have recently made changes to their positions in CME. Capital International Investors boosted its holdings in CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares during the period. Geode Capital Management LLC lifted its position in shares of CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after purchasing an additional 142,692 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd boosted its stake in shares of CME Group by 1.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after purchasing an additional 43,293 shares during the period. Finally, Raymond James & Associates grew its holdings in CME Group by 3.2% during the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after purchasing an additional 94,302 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,621 shares of company stock worth $3,441,063. Corporate insiders own 0.30% of the company’s stock.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.02%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is 48.37%.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.